NOVOEIGHT
antihemophilic factor recombinant · KIT · Novo Nordisk
No Recall History
Plain English
Novoeight is a recombinant antihemophilic factor used to treat hemophilia A by helping the blood clot properly. It is supplied as a kit for injection and is available over-the-counter.
Key Facts
- Brand Name
- NOVOEIGHT
- Generic Name
- antihemophilic factor recombinant
- NDC Code (Product)
0169-7815- Manufacturer
- Novo Nordisk
- Dosage Form
- KIT
- Marketing Status
- Application #
- BLA125466
- Marketing Start
- 04/01/2015
Recall History
No Recall HistoryFrequently Asked Questions
What is NOVOEIGHT used for?
Novoeight is a recombinant antihemophilic factor used to treat hemophilia A by helping the blood clot properly. It is supplied as a kit for injection and is available over-the-counter.
Is NOVOEIGHT a controlled substance?
NOVOEIGHT is not classified as a controlled substance by the DEA.
What is the generic name for NOVOEIGHT?
The generic name for NOVOEIGHT is antihemophilic factor recombinant. There are 5 other brand versions of antihemophilic factor recombinant.
What is the NDC code for NOVOEIGHT ?
The NDC (National Drug Code) for NOVOEIGHT is 0169-7815, listed by Novo Nordisk.